Composiciones farmacéuticas que comprenden everolimus
Una formulación farmacéutica que comprende una primera parte y una segunda parte, en la que la primera parte comprende una capa con, en base al peso de la capa, más del 40% en peso de 40-O-(2-hidroxi)etil-rapamicina, y la segunda parte libera más de 85% en peso de 40-O-(2-hidroxi)etil-rapamicina de...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | spa |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | KUNZLER, Hans-Ulrich DIEDERICH, Anke GRANER, Oliver |
| description | Una formulación farmacéutica que comprende una primera parte y una segunda parte, en la que la primera parte comprende una capa con, en base al peso de la capa, más del 40% en peso de 40-O-(2-hidroxi)etil-rapamicina, y la segunda parte libera más de 85% en peso de 40-O-(2-hidroxi)etil-rapamicina de la segunda parte en menos de 60 minutos.
The invention relates to a pharmaceutical formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a high drug load part and an immediate release part. In addition, the invention relates to a formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a first layer and a surfactant in a layer beneath the first layer. The pharmaceutical composition is particularly suitable for use as a medicament. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ES2633496TT3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ES2633496TT3</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ES2633496TT33</originalsourceid><addsrcrecordid>eNrjZDBzzs8tyC_OTM7Mz0stVkhLLMpNTD68srQkMzmxWKGwNFUhGaigKDUvJTVPIbUstSg_JzO3tJiHgTUtMac4lRdKczMourmGOHvophbkx6cWFyQmp-allsS7BhuZGRubWJqFhBgbE6MGAF70L5w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Composiciones farmacéuticas que comprenden everolimus</title><source>esp@cenet</source><creator>KUNZLER, Hans-Ulrich ; DIEDERICH, Anke ; GRANER, Oliver</creator><creatorcontrib>KUNZLER, Hans-Ulrich ; DIEDERICH, Anke ; GRANER, Oliver</creatorcontrib><description>Una formulación farmacéutica que comprende una primera parte y una segunda parte, en la que la primera parte comprende una capa con, en base al peso de la capa, más del 40% en peso de 40-O-(2-hidroxi)etil-rapamicina, y la segunda parte libera más de 85% en peso de 40-O-(2-hidroxi)etil-rapamicina de la segunda parte en menos de 60 minutos.
The invention relates to a pharmaceutical formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a high drug load part and an immediate release part. In addition, the invention relates to a formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a first layer and a surfactant in a layer beneath the first layer. The pharmaceutical composition is particularly suitable for use as a medicament.</description><language>spa</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170921&DB=EPODOC&CC=ES&NR=2633496T3$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170921&DB=EPODOC&CC=ES&NR=2633496T3$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>KUNZLER, Hans-Ulrich</creatorcontrib><creatorcontrib>DIEDERICH, Anke</creatorcontrib><creatorcontrib>GRANER, Oliver</creatorcontrib><title>Composiciones farmacéuticas que comprenden everolimus</title><description>Una formulación farmacéutica que comprende una primera parte y una segunda parte, en la que la primera parte comprende una capa con, en base al peso de la capa, más del 40% en peso de 40-O-(2-hidroxi)etil-rapamicina, y la segunda parte libera más de 85% en peso de 40-O-(2-hidroxi)etil-rapamicina de la segunda parte en menos de 60 minutos.
The invention relates to a pharmaceutical formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a high drug load part and an immediate release part. In addition, the invention relates to a formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a first layer and a surfactant in a layer beneath the first layer. The pharmaceutical composition is particularly suitable for use as a medicament.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBzzs8tyC_OTM7Mz0stVkhLLMpNTD68srQkMzmxWKGwNFUhGaigKDUvJTVPIbUstSg_JzO3tJiHgTUtMac4lRdKczMourmGOHvophbkx6cWFyQmp-allsS7BhuZGRubWJqFhBgbE6MGAF70L5w</recordid><startdate>20170921</startdate><enddate>20170921</enddate><creator>KUNZLER, Hans-Ulrich</creator><creator>DIEDERICH, Anke</creator><creator>GRANER, Oliver</creator><scope>EVB</scope></search><sort><creationdate>20170921</creationdate><title>Composiciones farmacéuticas que comprenden everolimus</title><author>KUNZLER, Hans-Ulrich ; DIEDERICH, Anke ; GRANER, Oliver</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ES2633496TT33</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>spa</language><creationdate>2017</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>KUNZLER, Hans-Ulrich</creatorcontrib><creatorcontrib>DIEDERICH, Anke</creatorcontrib><creatorcontrib>GRANER, Oliver</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>KUNZLER, Hans-Ulrich</au><au>DIEDERICH, Anke</au><au>GRANER, Oliver</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Composiciones farmacéuticas que comprenden everolimus</title><date>2017-09-21</date><risdate>2017</risdate><abstract>Una formulación farmacéutica que comprende una primera parte y una segunda parte, en la que la primera parte comprende una capa con, en base al peso de la capa, más del 40% en peso de 40-O-(2-hidroxi)etil-rapamicina, y la segunda parte libera más de 85% en peso de 40-O-(2-hidroxi)etil-rapamicina de la segunda parte en menos de 60 minutos.
The invention relates to a pharmaceutical formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a high drug load part and an immediate release part. In addition, the invention relates to a formulation comprising 40-O-(2-hydroxy)ethyl-rapamycin in a first layer and a surfactant in a layer beneath the first layer. The pharmaceutical composition is particularly suitable for use as a medicament.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | spa |
| recordid | cdi_epo_espacenet_ES2633496TT3 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | Composiciones farmacéuticas que comprenden everolimus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T01%3A51%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=KUNZLER,%20Hans-Ulrich&rft.date=2017-09-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EES2633496TT3%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |